摘要
目的探讨重组人脑利钠肽治疗老年慢性心衰急性加重期的临床效果。方法我院收治慢性心衰急性加重期患者共80例。对患者进行随机分组处理,观察组与对照组各为40例。对照组患者以硝普钠进行治疗,观察组患者以重组人脑利钠肽进行治疗,分析比较两组患者的临床疗效。结果观察组患者的治疗总有效率为95%,高于对照组80%,组间比较差异存在统计学意义(P<0.05)。结论重组人脑利钠肽治疗老年慢性心衰急性加重期的临床疗效显著,在一定程度上优于硝普钠治疗。
Objective To investigate the clinical effect of recombinant human brain natriuretic peptide in the treatment of acute exacerbation of elderly chronic heart failure. Methods A total of 80 patients with acute exacerbation of chronic heart failure were admitted in our hospital. Patients were randomly divided into two groups,the observation group and the control group were 40 cases. The control group patients were treated with sodium nitroprusside（SNP）,the observation group patients were treated with recombinant human brain natriuretic peptide and analysis were compared between the two groups of patients with clinical curative effect. Results The total effective rate of the observation group was 95%,higher than that of the control group（80%）,there was statistical difference between the two groups（P〈0.05）. Conclusion Recombinant human brain natriuretic peptide in the treatment of elderly patients with chronic heart failure acute exacerbation of clinical curative effect significantly,in a certain extent is better than that of sodium nitroprusside treatment.
出处
《中国卫生标准管理》
2016年第10期112-113,共2页
China Health Standard Management
关键词
重组人脑利钠肽
老年
慢性心衰急性加重期
临床疗效
Recombinant human brain natriuretic peptide
Old age
Chronic heart failure in acute aggravating period
Clinical curative effect
